MMP9 Expression Correlates With Cisplatin Resistance in Small Cell Lung Cancer Patients

• Главные авторы: Longqiu Wu (Автор), Xiangcai Wang (Автор), Xin He (Автор), Qiang Li (Автор), Qian Hua (Автор), Rongrong Liu (Автор), Zhengang Qiu (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: Cisplatin is the basis of the primary treatment for SCLC chemotherapy. However, the limited objective response rate and definite drug resistance greatly restrict the clinical potential and therapeutic benefits of cisplatin use. Therefore, it is essential to identify biomarkers that can d...